Actelion Pharmaceuticals US, Inc.

December 7, 2022 Actelion Pharmaceuticals faces a class action that alleges the company has illegally schemed to raise the unit price and quantity dispersed of certain high blood pressure drugs.

November 26, 2018 A proposed class action claims Actelion Pharmaceuticals unlawfully barred generic manufacturers from releasing generic versions of Tracleer, a prescription drug used to treat pulmonary artery hypertension, which would have lowered prices for consumers.